Related references
Note: Only part of the references are listed.Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections
Vijay Singh Gondil et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Trends in US Burden of Clostridioides difficile Infection and Outcomes
Alice Y. Guh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cell Wall Hydrolases in Bacteria: Insight on the Diversity of Cell Wall Amidases, Glycosidases and Peptidases Toward Peptidoglycan
Aurore Vermassen et al.
FRONTIERS IN MICROBIOLOGY (2019)
A Novel Bacteriophage Lysin-Human Defensin Fusion Protein Is Effective in Treatment of Clostridioides difficile Infection in Mice
Zhong Peng et al.
FRONTIERS IN MICROBIOLOGY (2019)
Synthetic biology of modular endolysins
Hans Gerstmans et al.
BIOTECHNOLOGY ADVANCES (2018)
Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
Vincent A. Fischetti
VIRUSES-BASEL (2018)
Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus?
Diana Gutierrez et al.
MBIO (2018)
Clostridium difficile - From Colonization to Infection
Holger Schaeffler et al.
FRONTIERS IN MICROBIOLOGY (2018)
Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Golnar Rahimzadeh et al.
JOURNAL OF PEDIATRICS REVIEW (2018)
The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review
Thomas V. Riley et al.
INFECTIOUS DISEASES AND THERAPY (2018)
Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model
Janet Y. Nale et al.
ANTIBIOTICS-BASEL (2018)
Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies
Hamed Haddad Kashani et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care
Michael J. Love et al.
ANTIBIOTICS-BASEL (2018)
Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology
Briony Elliott et al.
INFECTION GENETICS AND EVOLUTION (2017)
A Clostridioides difficile bacteriophage genome encodes functional binary toxin-associated genes
Thomas Riedel et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Hot topic: Antilisterial activity by endolysin PlyP100 in fresh cheese
Maxwell L. Van Tassel et al.
JOURNAL OF DAIRY SCIENCE (2017)
! Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)
Joan Totte et al.
TRIALS (2017)
A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus
Hamed Haddad Kashani et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact
Nienke Z. Borren et al.
PLOS ONE (2017)
Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with the Topical Endolysin Staphefekt SA. 100: A Report of 3 Cases
Joan E. E. Totte et al.
CASE REPORTS IN DERMATOLOGY (2017)
Expression of a Peptidoglycan Hydrolase from Lytic Bacteriophages Atu_ph02 and Atu_ph03 Triggers Lysis of Agrobacterium tumefaciens
Hedieh Attai et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Downregulation of Autolysin-Encoding Genes by Phage-Derived Lytic Proteins Inhibits Biofilm Formation in Staphylococcus aureus
Lucia Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo
Janet Y. Nale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Phage lytic proteins: biotechnological applications beyond clinical antimicrobials
Lorena Rodriguez-Rubio et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria
Hans Gerstmans et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile
Krunal K. Mehta et al.
BIOTECHNOLOGY AND BIOENGINEERING (2016)
Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease
Piklu Roy Chowdhury et al.
BMC MICROBIOLOGY (2016)
Creative lysins: Listeria and the engineering of antimicrobial enzymes
Maxwell L. Van Tassell et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
Alternatives to antibiotics-a pipeline portfolio review
Lloyd Czaplewski et al.
LANCET INFECTIOUS DISEASES (2016)
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Larry K. Kociolek et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Two Novel Myoviruses from the North of Iraq Reveal Insights into Clostridium difficile Phage Diversity and Biology
Srwa J. Rashid et al.
VIRUSES-BASEL (2016)
A bacteriophage endolysin that eliminates intracellular streptococci
Yang Shen et al.
ELIFE (2016)
Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity
Hugo Oliveira et al.
FRONTIERS IN MICROBIOLOGY (2016)
Clostridium difficile Infection
Jae Hyun Shin et al.
MICROBIOLOGY SPECTRUM (2016)
Clostridium difficile infection: a review of current and emerging therapies
Andrew Ofosu
ANNALS OF GASTROENTEROLOGY (2016)
Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection
Patrizia Spigaglia
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2016)
Clostridium difficile Infection and Fecal Microbiota Transplant
Alyssa Liubakka et al.
AACN ADVANCED CRITICAL CARE (2016)
Using a Novel Lysin To Help Control Clostridium difficile Infections
Qiong Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis
Mathias Schmelcher et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria
Yves Briers et al.
FUTURE MICROBIOLOGY (2015)
The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection
Xingmin Sun et al.
MOLECULAR IMMUNOLOGY (2015)
Clostridium difficile Infection
Daniel A. Leffler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Taxonomic Review of Clostridium difficile Phages and Proposal of a Novel Genus, Phimmp04likevirus
Katherine R. Hargreaves et al.
VIRUSES-BASEL (2015)
Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile (vol 6, e01112, 2015)
Pierre Boudry et al.
MBIO (2015)
New Role for Human alpha-Defensin 5 in the Fight against Hypervirulent Clostridium difficile Strains
Lucinda Furci et al.
INFECTION AND IMMUNITY (2015)
A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method
Hang Yang et al.
SCIENTIFIC REPORTS (2015)
Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile
Pierre Boudry et al.
MBIO (2015)
Complete Genome Sequence of the Novel Temperate Clostridium difficile Phage phiCDIF1296T
Johannes Wittmann et al.
GENOME ANNOUNCEMENTS (2015)
Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Narrow-Host-Range Bacteriophages That Infect Rhizobium etli Associate with Distinct Genomic Types
Rosa Isela Santamaria et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Characterization of Temperate Phages Infecting Clostridium difficile Isolates of Human and Animal Origins
Ognjen Sekulovic et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Expression and delivery of an endolysin to combat Clostridium perfringens
Teresa Gervasi et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Phage Lysis: Three Steps, Three Choices, One Outcome
Ryland Young
JOURNAL OF MICROBIOLOGY (2014)
Application of Lactobacillus johnsonii expressing phage endolysin for control of Clostridium perfringens
T. Gervasi et al.
LETTERS IN APPLIED MICROBIOLOGY (2014)
Deciphering key features in protein structures with the new ENDscript server
Xavier Robert et al.
NUCLEIC ACIDS RESEARCH (2014)
What Does the Talking? Quorum Sensing Signalling Genes Discovered in a Bacteriophage Genome
Katherine R. Hargreaves et al.
PLOS ONE (2014)
Engineered Endolysin-Based Artilysins To Combat Multidrug-Resistant Gram-Negative Pathogens
Yves Briers et al.
MBIO (2014)
Abundant and Diverse Clustered Regularly Interspaced Short Palindromic Repeat Spacers in Clostridium difficile Strains and Prophages Target Multiple Phage Types within This Pathogen
Katherine R. Hargreaves et al.
MBIO (2014)
Clostridium difficile phages: Still difficult?
Katherine R. Hargreaves et al.
FRONTIERS IN MICROBIOLOGY (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Novel Bacteriophage Lysin with Broad Lytic Activity Protects against Mixed Infection by Streptococcus pyogenes and Methicillin-Resistant Staphylococcus aureus
Daniel B. Gilmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel avenues for Clostridium difficile infection drug discovery
Mario Zucca et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
Tanja Dapa et al.
JOURNAL OF BACTERIOLOGY (2013)
Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model
G. J. Hughes et al.
JOURNAL OF HOSPITAL INFECTION (2013)
Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection
Mary C. Rea et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Evidence of In Vivo Prophage Induction during Clostridium difficile Infection
Mathieu Meessen-Pinard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2012)
Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria
Kyong-Hoon Choi et al.
CHEMICAL COMMUNICATIONS (2012)
Consequences of Clostridium difficile infection: understanding the healthcare burden
E. Bouza
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Bacteriophage endolysins as novel antimicrobials
Mathias Schmelcher et al.
FUTURE MICROBIOLOGY (2012)
The Spanin Complex Is Essential for Lambda Lysis
Joel Berry et al.
JOURNAL OF BACTERIOLOGY (2012)
Mycobacteriophage Endolysins: Diverse and Modular Enzymes with Multiple Catalytic Activities
Kimberly M. Payne et al.
PLOS ONE (2012)
Bacteriophage endolysins as a response to emerging foodborne pathogens
Hugo Oliveira et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2012)
A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus Strains
Mina Pastagia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vitro Destruction of Streptococcus pneumoniae Biofilms with Bacterial and Phage Peptidoglycan Hydrolases
Mirian Domenech et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Food applications of bacterial cell wall hydrolases
Lien Callewaert et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
The influence of external factors on bacteriophages-review
E. Jonczyk et al.
FOLIA MICROBIOLOGICA (2011)
Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa
Y. Briers et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
Prophage-Stimulated Toxin Production in Clostridium difficile NAP1/027 Lysogens
Ognjen Sekulovic et al.
JOURNAL OF BACTERIOLOGY (2011)
Structure-Based Modification of a Clostridium difficile-Targeting Endolysin Affects Activity and Host Range
Melinda J. Mayer et al.
JOURNAL OF BACTERIOLOGY (2011)
Clostridium difficile Has an Original Peptidoglycan Structure with a High Level of N-Acetylglucosamine Deacetylation and Mainly 3-3 Cross-links
Johann Peltier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus
Anu Daniel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Genome analysis of the Clostridium difficile phage ΦCD6356, a temperate phage of the Siphoviridae family
Marianne Horgan et al.
GENE (2010)
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Vincent A. Fischetti
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
The lambda spanin components Rz and Rz1 undergo tertiary and quaternary rearrangements upon complex formation
Joel Berry et al.
PROTEIN SCIENCE (2010)
The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144
Yves Briers et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia
Martin Witzenrath et al.
CRITICAL CARE MEDICINE (2009)
Bacteriophage and their lysins for elimination of infectious bacteria
Sarah O'Flaherty et al.
FEMS MICROBIOLOGY REVIEWS (2009)
Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria
Arnold J. Kell et al.
ACS NANO (2008)
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
Monty Liong et al.
ACS NANO (2008)
Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin
Melinda J. Mayer et al.
JOURNAL OF BACTERIOLOGY (2008)
Identification and functional analysis of the Rz/Rz1-like accessory lysis genes in the membrane-containing bacteriophage PRD1
Mart Krupovic et al.
MOLECULAR MICROBIOLOGY (2008)
Peptidoglycan structure and architecture
Waldemar Vollmer et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Bacterial peptidoglycan (murein) hydrolases
Waldemar Vollmer et al.
FEMS MICROBIOLOGY REVIEWS (2008)
LambdaSal and LambdaSa2 prophage lysins of Streptococcus agalactiae
David G. Pritchard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φMR11
Mohammad Rashel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The complete genome sequence of Clostridium difficile phage φC2 and comparisons to φCD119 and inducible prophages of CD630
Shan Goh et al.
MICROBIOLOGY-SGM (2007)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Genomic organization and molecular characterization of Clostridium difficile bacteriophage ΦCD119
R Govind et al.
JOURNAL OF BACTERIOLOGY (2006)
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats
JM Entenza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant Staphylococci, including methicillin-resistant Staphylococcus aureus
S O'Flaherty et al.
JOURNAL OF BACTERIOLOGY (2005)
Bacteriophage endolysins - current state of research and applications
MJ Loessner
CURRENT OPINION IN MICROBIOLOGY (2005)
Isolation and characterization of temperate bacteriophages of Clostridium difficile
S Goh et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles
SCJ Steiniger et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia
JM Loeffler et al.
INFECTION AND IMMUNITY (2003)
Pharmacokinetic principles of bacteriophage therapy
RJH Payne et al.
CLINICAL PHARMACOKINETICS (2003)
A bacteriolytic agent that detects and kills Bacillus anthracis
R Schuch et al.
NATURE (2002)
C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates
MJ Loessner et al.
MOLECULAR MICROBIOLOGY (2002)
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase
JM Loeffler et al.
SCIENCE (2001)
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
D Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
